A window into the human immune system: comprehensive characterization of the complexity of antibody complementary-determining regions in functional antibodies

References

• Kienzler A-K, Eibel H. Human B cell development and tolerance. In: Ratcliffe MJH, editor. Encyclopedia of immunobiology. United Kingdom: Elsevier; 2016. p. 105–12.
   Google Scholar
• Chi X, Li Y, Qiu X. V(D)J recombination, somatic hypermutation and class switch recombination of immunoglobulins: mechanism and regulation. Immunology. 2020;160(3):233–47. doi:10.1111/imm.13176.
   PubMed Web of Science ®Google Scholar
• Schroeder HW. The evolution and development of the antibody repertoire. Front Immunol. 2015;6:6. doi:10.3389/fimmu.2015.00033.
   PubMed Web of Science ®Google Scholar
• Tonegawa S. Somatic generation of antibody diversity. Nature. 1983;302(5909):575–81. doi:10.1038/302575a0.
   PubMed Web of Science ®Google Scholar
• Kunik V, Peters B, Ofran Y, Baker B. Structural consensus among antibodies defines the antigen binding site. PLoS Comput Biol [Internet]. 2012;8(2):e1002388. [accessed 2022 Nov 16]. doi:10.1371/journal.pcbi.1002388.
   PubMed Web of Science ®Google Scholar
• Davies DR, Cohen GH Interactions of protein antigens with antibodies. Proc Natl Acad Sci USA. 1996;93(1):7–12.
   PubMed Web of Science ®Google Scholar
• Davies DR, Padlan EA, Sheriff S. Antibody-antigen complexes. Annu Rev Biochem. 1990;59(1):439–73. doi:10.1146/annurev.bi.59.070190.002255.
   PubMedGoogle Scholar
• Fellouse FA, Wiesmann C, Sidhu SS. Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition. Proc Natl Acad Sci U S A. 2004;101(34):12467–72. doi:10.1073/pnas.0401786101.
   PubMed Web of Science ®Google Scholar
• Fellouse FA, Esaki K, Birtalan S, Raptis D, Cancasci VJ, Koide A, Jhurani P, Vasser M, Wiesmann C, Kossiakoff AA, et al. High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries. J Mol Biol. 2007;373(4):924–40. doi:10.1016/j.jmb.2007.08.005.
   PubMed Web of Science ®Google Scholar
• Nguyen MN, Pradhan MR, Verma C, Zhong P, Valencia A. The interfacial character of antibody paratopes: analysis of antibody–antigen structures. Bioinformatics [Internet]. 2017;33:2971–76. [accessed 2022 Nov 16]. doi:10.1093/bioinformatics/btx389. https://pubmed.ncbi.nlm.nih.gov/28633399/.
   PubMed Web of Science ®Google Scholar
• Wang M, Zhu D, Zhu J, Nussinov R, Ma B. Local and global anatomy of antibody-protein antigen recognition. J Mol Recog [Internet]. 2018; 31:e2693. accessed 2022 Nov 16. doi:10.1002/jmr.2693.
   PubMed Web of Science ®Google Scholar
• Winter G, Milstein C. Man-made antibodies. Nature. 1991;349(6307):293–99. doi:10.1038/349293a0.
   PubMed Web of Science ®Google Scholar
• Lu R-M, Hwang Y-C, Liu I-J, Lee C-C, Tsai H-Z, Li H-J, Wu H-C. Development of therapeutic antibodies for the treatment of diseases. J Biomed Sci. 2020;27(1):1. doi:10.1186/s12929-019-0592-z.
   PubMed Web of Science ®Google Scholar
• Akbar R, Robert PA, Pavlović M, Jeliazkov JR, Snapkov I, Slabodkin A, Weber CR, Scheffer L, Miho E, Haff IH, et al. A compact vocabulary of paratope-epitope interactions enables predictability of antibody-antigen binding. Cell Rep. 2021;34(11):108856. doi:10.1016/j.celrep.2021.108856.
   PubMed Web of Science ®Google Scholar
• Shi B, Ma L, He X, Wang X, Wang P, Zhou L, Yao X. Comparative analysis of human and mouse immunoglobulin variable heavy regions from IMGT/LIGM-DB with IMGT/HighV-QUEST. Theor Biol Med Model. 2014;11(1):30. doi:10.1186/1742-4682-11-30.
   PubMedGoogle Scholar
• Wu L, Oficjalska K, Lambert M, Fennell BJ, Darmanin-Sheehan A, Ní Shúilleabháin D, Autin B, Cummins E, Tchistiakova L, Bloom L, et al. Fundamental characteristics of the immunoglobulin VH repertoire of Chickens in comparison with those of Humans, mice, and camelids. J Immunol. 2012;188(1):322–33. doi:10.4049/jimmunol.1102466.
   PubMed Web of Science ®Google Scholar
• Ivanov II, Schelonka RL, Zhuang Y, Gartland GL, Zemlin M, Schroeder HW. Development of the Expressed Ig CDR-H3 repertoire is Marked by focusing of constraints in length, amino acid use, and charge that are first established in early B cell progenitors. J Immunol. 2005;174:7773–80. doi:10.4049/jimmunol.174.12.7773.
   PubMed Web of Science ®Google Scholar
• Lefranc M-P, Giudicelli V, Duroux P, Jabado-Michaloud J, Folch G, Aouinti S, Carillon E, Duvergey H, Houles A, Paysan-Lafosse T, et al. IMGT®, the international ImMunoGeneTics information system® 25 years on. Nucleic Acids Res. 2015;43(D1):D413–22. doi:10.1093/nar/gku1056.
   PubMed Web of Science ®Google Scholar
• Gromiha MM, Suwa M. A simple statistical method for discriminating outer membrane proteins with better accuracy. Bioinformatics [Internet]. 2005;21(7):961–68. [accessed 2022 Nov 10]. doi:10.1093/bioinformatics/bti126.
   PubMed Web of Science ®Google Scholar
• Pommié C, Levadoux S, Sabatier R, Lefranc G, Lefranc MP. IMGT standardized criteria for statistical analysis of immunoglobulin V-REGION amino acid properties. J Mol Recognit [Internet]. 2004;17:17–32. [accessed 2022 Nov 11]. doi:10.1002/jmr.647. https://pubmed.ncbi.nlm.nih.gov/14872534/.
   PubMed Web of Science ®Google Scholar
• Kabat EA, Wu TT, Bilofsky H. Unusual distributions of amino acids in complementarity-determining (hypervariable) segments of heavy and light chains of immunoglobulins and their possible roles in specificity of antibody-combining sites. J Biol Chem. 1977;252(19):6609–16. doi:10.1016/S0021-9258(17)39891-5.
   PubMed Web of Science ®Google Scholar
• Lee A, Desravines S, Hsu E. IgH diversity in an individual with only one million B lymphocytes. Dev Immunol. 1993;3(3):211–22. doi:10.1155/1993/17249.
   PubMedGoogle Scholar
• Volpe JM, Kepler TB. Large-scale analysis of human heavy chain V(D)J recombination patterns. Immunome Res [Internet]. 2008;4:3. [accessed 2022 Nov 14]. doi:10.1186/1745-7580-4-3. /pmc/articles/PMC2275228/.
   PubMedGoogle Scholar
• Zemlin M, Klinger M, Link J, Zemlin C, Bauer K, Engler JA, Schroeder HW, Kirkham PM. Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures. J Mol Biol. 2003;334(4):733–49. doi:10.1016/j.jmb.2003.10.007.
   PubMed Web of Science ®Google Scholar
• Wu T, Te Johnson G, Kabat EA. Length distribution of CDRH3 in antibodies. Proteins: Struct Funct Genet. 1993;16:1–7. doi:10.1002/prot.340160102.
   PubMed Web of Science ®Google Scholar
• Hong B, Wu Y, Li W, Wang X, Wen Y, Jiang S, Dimitrov DS, Ying T. In-depth analysis of human neonatal and adult IgM antibody repertoires. Front Immunol [Internet]. 2018; 9:128. [accessed 2022 Nov 14]. doi:10.3389/fimmu.2018.00128. /pmc/articles/PMC5807330/.
   PubMed Web of Science ®Google Scholar
• Briney BS, Willis JR, Hicar MD, Thomas JW, Crowe JE. Frequency and genetic characterization of V(DD)J recombinants in the human peripheral blood antibody repertoire. Immunology [Internet]. 2012;137:56. [accessed 2022 Nov 14]. doi:10.1111/j.1365-2567.2012.03605.x. /pmc/articles/PMC3449247/.
   PubMed Web of Science ®Google Scholar
• Chen L, Duan Y, Benatuil L, Stine WB. Analysis of 5518 unique, productively rearranged human VH3-23*01 gene sequences reveals CDR-H3 length-dependent usage of the IGHD2 gene family. Protein Eng Des Sel. 2017;30(9):603–09. doi:10.1093/protein/gzx027.
   PubMed Web of Science ®Google Scholar
• Peng HP, Lee KH, Jian JW, Yang AS. Origins of specificity and affinity in antibody-protein interactions. Proc Natl Acad Sci U S A. 2014;111:E2656–65. accessed 2022 Nov 14. doi:10.1073/pnas.1401131111.
   PubMed Web of Science ®Google Scholar
• Bischoff R, Schlüter H. Amino acids: chemistry, functionality and selected non-enzymatic post-translational modifications. J Proteomics. 2012;75(8):2275–96. doi:10.1016/j.jprot.2012.01.041.
   PubMed Web of Science ®Google Scholar
• Ofran Y, Schlessinger A, Rost B. Automated identification of complementarity Determining regions (CDRs) reveals peculiar characteristics of CDRs and B cell epitopes. J Immunol [Internet]. 2008;181(9):6230–35. [accessed 2022 Nov 14]. doi:10.4049/jimmunol.181.9.6230.
   PubMed Web of Science ®Google Scholar
• Crowley PB, Golovin A. Cation-π interactions in protein-protein interfaces. Proteins Struct Funct Bioinf. 2005;59(2):231–39. doi:10.1002/prot.20417.
   PubMed Web of Science ®Google Scholar
• Yu C-M, Peng H-P, Chen I-C, Lee Y-C, Chen J-B, Tsai K-C, Chen C-T, Chang J-Y, Yang E-W, Hsu P-C, et al. Rationalization and design of the complementarity Determining region sequences in an antibody-antigen recognition interface. PloS One. 2012;7(3):e33340. doi:10.1371/journal.pone.0033340.
   PubMed Web of Science ®Google Scholar
• Moreira IS, Fernandes PA, Ramos MJ. Hot spots—A review of the protein–protein interface determinant amino-acid residues. Proteins: Struct, Funct, And Bioinfor [Internet]. 2007;68:803–12. [accessed 2022 Nov 14]. doi:10.1002/prot.21396.
   PubMed Web of Science ®Google Scholar
• Birtalan S, Zhang Y, Fellouse FA, Shao L, Schaefer G, Sidhu SS. The intrinsic contributions of tyrosine, serine, glycine and arginine to the affinity and specificity of antibodies. J Mol Biol. 2008;377(5):1518–28. doi:10.1016/j.jmb.2008.01.093.
   PubMed Web of Science ®Google Scholar
• Koide S, Sidhu SS. The importance of being tyrosine: lessons in molecular recognition from minimalist synthetic binding proteins. ACS Chem Biol [Internet]. 2009;4:325–34. [accessed 2022 Nov 14]. doi:10.1021/cb800314v.
   PubMed Web of Science ®Google Scholar
• Tiller KE, Li L, Kumar S, Julian MC, Garde S, Tessier PM. Arginine mutations in antibody complementarity-determining regions display context-dependent affinity/specificity trade-offs. J Biol Chem. 2017;292(40):16638–52. doi:10.1074/jbc.M117.783837.
   PubMed Web of Science ®Google Scholar
• DeKosky BJ, Lungu OI, Park D, Johnson EL, Charab W, Chrysostomou C, Kuroda D, Ellington AD, Ippolito GC, Gray JJ, et al. Large-scale sequence and structural comparisons of human naive and antigen-experienced antibody repertoires. Proc Natl Acad Sci USA 2016;113(19):113.
   Web of Science ®Google Scholar
• Bogan AA, Thorn KS. Anatomy of hot spots in protein interfaces. J Mol Biol. 1998;280(1):1–9. doi:10.1006/jmbi.1998.1843.
   PubMed Web of Science ®Google Scholar
• Aledo JC, Cantón FR, Veredas FJ. Sulphur atoms from Methionines Interacting with aromatic residues are less prone to oxidation. Sci Rep [Internet]. 2015;5:1–14. [accessed 2022 Nov 14]. doi:10.1038/srep16955.
   Web of Science ®Google Scholar
• Valley CC, Cembran A, Perlmutter JD, Lewis AK, Labello NP, Gao J, Sachs JN. The methionine-aromatic motif plays a unique role in stabilizing protein structure. J Biol Chem [Internet]. 2012;287(42):34979–91. [accessed 2022 Nov 14]. doi:10.1074/jbc.M112.374504.
   PubMed Web of Science ®Google Scholar
• Arbabi-Ghahroudi M. Camelid Single-Domain antibodies: historical perspective and future outlook. Front Immunol. 2017;8:1589. doi:10.3389/fimmu.2017.01589.
   PubMed Web of Science ®Google Scholar
• Almagro JC, Raghunathan G, Beil E, Janecki DJ, Chen Q, Dinh T, Lacombe A, Connor J, Ware M, Kim PH, et al. Characterization of a high-affinity human antibody with a disulfide bridge in the third complementarity-determining region of the heavy chain. J Mol Recog [Internet]. 2012;25:125–35. [accessed 2022 Nov 14]. doi:10.1002/jmr.1168.
   PubMed Web of Science ®Google Scholar
• Hu Z, Ma B, Wolfson H, Nussinov R. Conservation of polar residues as hot spots at protein interfaces. Proteins Struct Funct Bioinf [Internet]. 2000;39:331–42. doi:10.1002/(SICI)1097-0134(20000601)39:4<331:AID-PROT60>3.0.CO.
   PubMed Web of Science ®Google Scholar
• Otaki JM, Tsutsumi M, Gotoh T, Yamamoto H. Secondary structure characterization based on amino acid composition and availability in proteins. J Chem Inf Model [Internet]. 2010;50:690–700. [accessed 2022 Nov 15]. doi:10.1021/ci900452z.
   PubMed Web of Science ®Google Scholar
• Giudicelli V, Duroux P, Ginestoux C, Folch G, Jabado-Michaloud J, Chaume D, Lefranc MP. IMGT/LIGM-DB, the IMGT® comprehensive database of immunoglobulin and T cell receptor nucleotide sequences. Nucleic Acids Res [Internet]. 2006;34:D781–4. [accessed 2022 Jun 17]. doi:10.1093/nar/gkj088. https://academic.oup.com/nar/article/34/suppl_1/D781/1133248.
   PubMed Web of Science ®Google Scholar
• Alamyar E, Duroux P, Lefranc MP, Giudicelli V. IMGT(®) tools for the nucleotide analysis of immunoglobulin (IG) and T cell receptor (TR) V-(D)-J repertoires, polymorphisms, and IG mutations: IMGT/V-QUEST and IMGT/HighV-QUEST for NGS. Methods Mol Biol [Internet]. 2012;882:569–604. [accessed 2022 Jun 17]. https://pubmed.ncbi.nlm.nih.gov/22665256/.
   PubMedGoogle Scholar
• Li S, Lefranc MP, Miles JJ, Alamyar E, Giudicelli V, Duroux P, Freeman JD, Corbin VDA, Scheerlinck JP, Frohman MA, et al. Imgt/highv QUEST paradigm for T cell receptor IMGT clonotype diversity and next generation repertoire immunoprofiling. Nat Commun [Internet]. 2013;4(1): [accessed 2022 Jun 17]. doi:10.1038/ncomms3333.
   Google Scholar
• G V. From IMGT-ONTOLOGY to IMGT/HighVQUEST for NGS immunoglobulin (IG) and T cell receptor (TR) repertoires in autoimmune and infectious diseases. Autoimmun And Infec Dis: Open Access (ISSN 2470-1025). 2015;1:1. doi:10.16966/2470-1025.103.
   Google Scholar
• Aouinti S, Malouche D, Giudicelli V, Kossida S, Lefranc MP, Allen RL. IMGT/HighV-QUEST statistical significance of IMGT clonotype (AA) diversity per gene for standardized comparisons of next generation sequencing immunoprofiles of immunoglobulins and T cell receptors. PloS One. 2015;10(11):10. doi:10.1371/journal.pone.0142353.
   Web of Science ®Google Scholar
• Swindells MB, Porter CT, Couch M, Hurst J, Abhinandan KR, Nielsen JH, Macindoe G, Hetherington J, Martin ACR. abYsis: Integrated antibody sequence and structure—management, analysis, and prediction. J Mol Biol. 2017;429:356–64. doi:10.1016/j.jmb.2016.08.019.
   PubMed Web of Science ®Google Scholar
• Pegram MD, Lipton A, Hayes DF, Weber BL, Baselga JM, Tripathy D, Baly D, Baughman SA, Twaddell T, Glaspy JA, et al. Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment. J Clin Oncol. 1998;16:2659–71. doi:10.1200/JCO20161682659.
   PubMed Web of Science ®Google Scholar